Posted on
Summary
The TAPM - Early Clinical Development provides project management leadership for the cross-functional CDRA teams (eg: PVRM, Regulatory, Medical Monitoring, Clinical and Program Finance, Clinical Operations, etc.). Manages therapeutic areas clinical projects by overseeing the initiating, planning, execution, and closeout of the clinical development plans for clinical programs. Facilitates strategic planning for operational plans with CDRA and external partners as appropriate.
Responsibilities
Experience And Required Skills :
Requirements:
• Strong interpersonal & leadership skills
• Ability to provide strategic direction and guidance to teams aligned with clinical development plans
• Anticipates new trends in a competitive landscape and therapeutic areas to guide the organizational strategy
• Provides a comprehensive industry perspective for project management execution
• Strong analytical skills with a data-driven approach to planning, executing, and problem-solving
• Effective communication skills to all levels of the organization
• Proactive and self-disciplined, ability to meet deadlines, effective use of time, and prioritization
• Accomplished influencing and negotiation skills
• Proficient in creating and maintaining clinical program budgets and timelines
• Exceptional project management, cross-functional team leadership, and organizational skills
• Ability to build successful and effective teams and collaborations internally as well as with external partners
• Line management experience with demonstrated mentoring and coaching skills
• In-depth knowledge of GCP and ICH
Education:
• Masters or doctoral level (PhD, PharmD, MD, MBA); undergraduate technical/scientific degree
Experience
• 15 years relevant FDA regulated industry experience preferably with drug development; at least ten of which are in project management
Certifications
• Project Management Professional (PMP)® - preferred
• NIH certification on the Protection of Human Research Subjects - preferred
Our Client is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, their unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in their own laboratories. Their medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases and rare diseases.